Generic Name and Formulations:
Purified water, MultiSal Neolipids*, glyceryl stearate, squalane, glycerin, PEG-100 stearate, hydroxypropyl bispalmitamide MEA (ceramide), petrolatum, dimethicone, phenoxyethanol, cholesterol, conjugated linoleic acid, citric acid, palmitic acid, xanthan gum, potassium hydroxide, disodium EDTA, sorbic acid, capric acid; controlled-release skin barrier emulsion; steroid-, fragrance-free. *Proprietary microencapsulation system for gradual delivery of key ingredients including ceramide, conjugated linoleic acid,cholesterol and palmitic acid (formulated with E.Cerifera [Candelilla] wax, corn syrup solids and modified food starch).
Indications for EPICERAM:
To treat dry skin conditions and to manage and relieve burning and itching associated with various types of dermatoses, including atopic dermatitis, irritant contact dermatitis, and radiation dermatitis.
Adults and Children:
Apply thin layer to affected areas 2 times per day (or as needed). Massage gently into skin. If skin is broken, cover with dressing. Apply following radiation therapy.
Reevaluate if no improvement within 10–14 days. Use in conjunction with sunscreen in sun exposed areas.
Do not apply within 4hrs prior to radiation therapy.
Tingling sensation at application site.
Emulsion—90g (tube); 100g, 225g (airless pump); 400g (Quad Pack: 4×100g airless pumps)
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|